PDEX Pro-Dex Total Debt to Capital

PDEX (Pro-Dex, Inc.) - company brandmark

The market trend for the total debt-to-equity ratio of Pro-Dex, Inc. (PDEX) is 0.38, while the business relies on strict FDA certification and authority among OEM partners. Pro-Dex, Inc. (PDEX) procures steel and drives from third-party suppliers, completing the assembly in-house. A rigorous interaction protocol with its contractor network eliminates vendor dependency risks during instrument production.

Debt to Equity Ratio: pro-dex.com (PDEX) for 07/04/2022 - 10/27/2026
Brand item of Pro-Dex Inc.

The financial stability of Pro-Dex, Inc. (PDEX) is supported by a diversified portfolio of contracts with global brands in the surgical instrumentation niche, which minimizes operational risks. The current value of 0.38 within the debt-to-equity ratio trend reflects the proportion of total liabilities relative to shareholders' equity, allowing investors to assess the business's dependence on creditors and its ability to maintain solvency.

Analysis of competing companies

Debt to Equity ISRG|Total Debt to Equity Ratio Danaher Corporation|Becton, Dickinson and Company - Total Debt to Capital|Debt to Capital STERIS Group (STE)|WST - Total Debt to Capital|Debt to Equity Ratio baxter.com BAX|Total Debt to Capital MASI (Masimo)|STVN - Total Debt to Capital Coefficient|TFX (Teleflex Inc) - Total Debt to Capital|Merit Medical Corp (MMSI) - Total Debt to Equity Ratio|NVST (Envista Holdings) - Total Debt to Capital|Total Debt to Capital ICUI|Debt to Equity Dentsply Sirona (XRAY)|Debt to Equity LeMaitre Vascular Inc LMAT|Total Debt to Equity Ratio AtriCure Corp|All Debt to Shareholders' Equity Ratio STAAR Surgical Co STAA|Total Debt to Capital NAGE (ChromaDex Corp.)|ZIMV: Total Debt to Capital Coefficient|Debt to Equity AngioDynamics|CERS (Cerus Corp.) - Debt to Equity Ratio|TKNO: Debt to Equity|Total Debt to Capital Coefficient Monogram Orthopedics Inc. (MGRM)|Total Debt to Equity Ratio Sharps Technology, Inc.|Aggregate Debt to Capital INFU (infusystem.com)|Debt to Equity Utah Medical Products, Inc.|KRMD - All Debt to Shareholders' Equity Ratio|Nyxoah, S.A. - Total Debt to Equity Ratio|MBOT: Total Debt to Capital|ZTEK (Zentek Ltd.) - Debt to Equity|elutia.com (ELUT) - Total Debt to Equity Ratio|Total Debt to Capital MLSS (Milestone Scientific Inc.)|Debt to Capital NXGL|Debt to Equity Retractable Technologies RVP|Debt to Equity Ratio harvardbioscience.com HBIO|Total Debt to Equity Ratio Femasys Inc. (FEMY)|Meihua Medical Technologies - Aggregate Debt to Capital|Debt to Equity POAI (Predictive Oncology Corp)|CJMB: Total Debt to Capital Coefficient|Debt to Equity Atrion Corp (ATRI)|NURO (NeuroMetrix Corporation) - Aggregate Debt to Equity